IP Verse

Use Of Nmn For The Prevention And/Or Treatment Of Pain, And Corresponding Compositions

Patent No. EP4028021 (titled "Use Of Nmn For The Prevention And/Or Treatment Of Pain, And Corresponding Compositions") was filed by Nuvamid on Sep 8, 2020. The application was issued on Jan 24, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SCHLICHMay 30, 2024SCHLICH

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4028021

NUVAMID
Application Number
EP20765054A
Filing Date
Sep 8, 2020
Status
Granted And Under Opposition
Dec 22, 2023
Publication Date
Jan 24, 2024
External Links
Slate, Register , Google Patents